ExpMED RZ (0717.836.721): financials and annual accounts

ExpMED RZ

Liège ·KBO/BCE: BE 0717.836.721

Line	2025	2024	2023	2022	2021	2020
Balance sheet: assets
Total assets`20/58`	173,104	210,225	259,625	410,433	283,667	338,679
Fixed assets`21/28`	106,777	144,595	177,928	217,386	162,916	182,537
Intangible fixed assets`21`	73,529	94,529	115,529	136,529	157,529	178,529
Tangible fixed assets`22/27`	33,248	50,066	62,399	80,857	5,387	4,008
Furniture and vehicles`24`	26,454	40,708	50,477	66,373	5,387	4,008
Other tangible fixed assets`26`	6,794	9,358	11,922	14,484	-	-
Current assets`29/58`	66,327	65,630	81,697	193,047	120,751	156,142
Amounts receivable within one year`40/41`	32,775	23,722	66,306	24,096	-	-
Trade receivables`40`	32,775	23,722	26,306	24,096	-	-
Other amounts receivable`41`	-	-	40,000	-	-	-
Cash at bank and in hand`54/58`	32,055	38,335	10,510	157,496	112,102	145,156
Deferred charges and accrued income`490/1`	1,497	3,573	4,881	11,455	8,649	10,986
Balance sheet: equity and liabilities
Total equity and liabilities`10/49`	173,104	210,225	259,625	410,433	283,667	338,679
Equity`10/15`	89,761	58,712	7,467	98,281	31,297	27,013
Contributions`10/11`	18,600	18,600	18,600	18,600	18,600	18,600
Issued capital`100`	-	-	-	-	-	18,600
Reserves`13`	70,000	75,000	75,000	75,000	5,000	5,000
Non-distributable reserves`130/1`	-	-	5,000	5,000	5,000	-
Legal reserve`130`	-	-	-	-	-	5,000
Reserves not available under the articles`1311`	-	-	5,000	5,000	5,000	-
Distributable reserves`133`	70,000	75,000	70,000	70,000	-	-
Profit (loss) carried forward`14`	1,161	-34,888	-86,133	4,681	7,697	3,413
Amounts payable`17/49`	83,343	151,513	252,158	312,152	252,370	311,666
Amounts payable after more than one year`17`	9,156	53,484	97,810	142,137	128,474	164,595
Financial debts`170/4`	9,156	53,484	97,810	142,137	128,474	164,595
Amounts payable within one year`42/48`	74,187	98,029	154,348	170,015	123,896	147,071
Current portion of amounts payable after more than one year`42`	44,327	44,327	44,327	44,327	32,118	28,116
Trade debts`44`	1,253	2,535	854	-	3,324	1,554
Suppliers`440/4`	1,253	2,535	854	-	3,324	1,554
Taxes, remuneration and social security`45`	23,695	12,269	11,630	67,945	39,011	55,562
Taxes`450/3`	23,695	12,269	11,630	67,945	39,011	55,562
Other amounts payable`47/48`	4,912	38,898	97,537	57,743	49,443	61,839
Income statement
Gross operating margin`9900`	100,163	92,334	-49,023	211,869	112,197	161,402
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets`630`	38,623	38,240	39,458	31,082	22,783	37,664
Other operating charges`640/8`	552	545	718	769	622	578
Operating profit (loss)`9901`	60,988	53,549	-89,199	180,018	88,792	123,160
Financial charges`65/66B`	1,341	2,128	2,697	3,116	3,416	4,032
Recurring financial charges`65`	1,341	2,128	2,697	3,066	3,416	4,032
Non-recurring financial charges`66B`	-	-	-	50	-	-
Profit (loss) for the period before taxes`9903`	59,647	51,421	-91,896	176,902	85,376	119,128
Income taxes`67/77`	10,598	176	-1,082	39,918	21,092	25,000
Profit (loss) for the period`9904`	49,049	51,245	-90,814	136,984	64,284	94,128
Profit (loss) for the period to be appropriated`9905`	49,049	51,245	-90,814	136,984	64,284	94,128
Appropriation of the result
Profit (loss) to be appropriated`9906`	14,161	-34,888	-86,133	144,681	67,697	94,128
Profit (loss) brought forward from the previous period`14P`	-34,888	-86,133	4,681	7,697	-	-
Transfer from equity`791/2`	5,000	-	-	-	-	-
Transfer to equity`691/2`	-	-	-	70,000	-	5,000
To the legal reserve`6920`	-	-	-	-	-	5,000
To other reserves`6921`	-	-	-	70,000	-	-
Profit to be distributed`694/7`	18,000	-	-	70,000	60,000	85,715
Return on contributions (dividend)`694`	18,000	-	-	70,000	60,000	85,715
Document	PDF	PDF	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
30-06-2025	micro format	29-12-2025	2025-00591311	PDF
30-06-2024	micro format	17-12-2024	2024-00620163	PDF
30-06-2023	micro format	30-11-2023	2023-00518690	PDF
30-06-2022	micro format	05-12-2022	2022-20531508	PDF
30-06-2021	micro format	29-12-2021	2021-81900462	PDF
30-06-2020	micro format	29-01-2021	2021-02400449	PDF

Line	2025	2024	2023	2022	2021	2020
EBITDA	99,611	91,789	-49,741	211,100	111,575	160,824
Cash flow	87,672	89,485	-51,356	168,066	87,067	131,792
Investment in fixed assets (approximation)	805	4,907	0	85,552	3,162	218,082
Change in cash	-6,280	27,825	-146,986	45,394	-33,054	-
Working capital	-7,860	-32,399	-72,651	23,032	-3,145	9,071
Solvency	51.9%	27.9%	2.9%	23.9%	11.0%	8.0%
Current ratio	0.89	0.67	0.53	1.14	0.97	1.06
Debt to equity	0.93	2.58	33.77	3.18	8.06	11.54
ROE	54.6%	87.3%	-	139.4%	205.4%	348.5%
ROA	28.3%	24.4%	-35.0%	33.4%	22.7%	27.8%
Interest coverage	74.28	43.13	-18.44	68.85	-	-

Item	30-06-2025	30-06-2024	30-06-2023	30-06-2022
Tangible fixed assets	€805	€4,907	-	€85,552
Depreciation and write-downs of the year	€38,623	€38,240	€39,458	€31,082

ExpMED RZ

Annual accounts 2025

Balance sheet

Change in equityin euro

Change in cashin euro

Position in the sector

Solvency51.9%

Current ratio0.89

Return on assets28.3%

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on ExpMED RZ

Next steps